Stock screener

NPCE

Conviction 51HealthcareScan · Mon, Aug 10, 2026
NPCE$14.84+0.07%
ResistanceSupportVol 14
63 bars
Vol MA14 308.7K
May 11May 28Jun 16Jul 6Jul 23Aug 10
NeuroPace IncSURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.neuropace.com
Price14.84
Change+0.07%
Gap-0.88%
Rel volume2.23×
Avg volume248.03K
Avg $ vol3.57M
SMA 2014.78
SMA 5015.61
SMA 20015.20
Price vs 50-4.96%
Price vs 200-2.35%
MA stackmixed
50/200 cross
Supertrenddown · 15.84
RSI (14)49
MACD hist0.05
MACD crossbull · 0d
Stoch %K / %D69 / 57
ADX (14)20
+DI / −DI20 / 26
RSI divergence
MACD divergence
ATR %+5.77%
ADR %5.72%
52w high19.29
52w low8.25
From 52w high-23.07%
Above 52w low+79.88%
New 52w highNo
SqueezeOff
Bollinger width26.82%
%B0.51
Donchian pos41.37%
Donchian high17.93
Donchian low12.66
AVWAP (52w high)15.62
vs AVWAP high-5.02%
AVWAP (52w low)14.24
vs AVWAP low+4.22%
OBV trendUp
Chaikin MF (20)-0.09
Today vs 20d2.23×
Avg vol (14d)308.7K
Avg vol (20d)248.03K
Avg $ vol (20d)3.57M
Market cap505.95M
RS 3m (vs SPY)-28.82%
RS 6m (vs SPY)-18.37%
RS line new highNo
Trend template5/8
Technical rank29.7
1 week+9.93%
1 month-13.27%
3 months-19.13%
6 months-5.30%
1 year+66.37%
YTD-2.18%
P/E-23.57
P/B35.00
P/S5.06
P/FCF-44.62
EPS-0.6600
Div yield
ROE-148.51%
ROA-21.70%
Debt/Eq4.08
Current5.38
EV/EBITDA
Gross margin77.23%
Net margin-21.47%
Rev growth25.13%
EPS growth20.91%
Price target
Target upside
Analyst rating
Institutional
Ent. value550.19M
Revenue22.07M
Net income-6.69M
Gross profit18.05M
Free cash flow-11.34M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out34.09M
Employees220
ListedThu, Apr 22, 2021
Free float22.03M
Float %66.1%
Short interest874.34K
Days to cover5.7d
Short volume44.8%
Squeeze score51 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeC
Conviction51 / 100
Pattern quality
Tech rank29.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance18.08
Support13.47
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NPCE

All disclosures →
No recent disclosed trades by Congress in NPCE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NPCE · 9 buys · 1 sell

InsiderSideShares
Morrell Martha
CHIEF MEDICAL OFFICER · Common Stock · 2026-06-24
Tax335
Fischer Frank M
Director · Common Stock · 2026-06-19
Grant1.47K
Geiger Uri
Director · Common Stock · 2026-06-19
Grant789
Kumar Rakhi
Director · Common Stock · 2026-06-19
Grant989
Fischer Frank M
Director · Common Stock · 2026-06-05
Grant2.89K
Huennekens R Scott
Director · Stock Option (Right to Buy) · 2026-06-05
Grant5.37K
Geiger Uri
Director · Stock Option (Right to Buy) · 2026-06-05
Grant5.37K
Geiger Uri
Director · Common Stock · 2026-06-05
Grant2.89K
Kumar Rakhi
Director · Common Stock · 2026-06-05
Grant2.89K
Ryan Renee
Director · Stock Option (Right to Buy) · 2026-06-05
Grant5.37K

SEC filings

EDGAR filings in NPCE · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.